 23andme CEO Anne Wojcicki joins The Exchange to discuss her companys planned acquisition of Lemonaid, a telehealth company, and the future of genetic integration in health. For access to live and exclusive video from CNBC subscribe to CNBC PRO: Subscribe to CNBC TV: Subscribe to CNBC: Subscribe to CNBC Classic: Turn to CNBC TV for the latest stock market news and analysis. 